Saturday 17 October 2026
Export GDRX’s income statement to Excel — free account
GoodRx Holdings, Inc.
GDRX Healthcare Health Information Services
GoodRx Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $796.9 million, up 0.57% from fiscal 2024. In the quarter to June 2026, revenue fell 1.31%, EPS fell 25.0%, free cash flow grew 112.5% and total debt was flat, each against the same quarter a year earlier.
3.36
0.15
−4.27%
Follow GDRX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 8 | 5 | 3 | 4 | 4 | — | — | — | — |
P/E ratio |
30.04 | 98.10 | 0.00 | 0.00 | 0.00 | 0.00 | 138.66 | 138.66 | 138.66 | 138.66 |
Altman Z-Score |
0.44 | 1.36 | 1.69 | 1.31 | 10.37 | 8.03 | — | — | — | — |
P/S ratio |
1.21 | 2.26 | 3.07 | 2.54 | 17.97 | 20.12 | 24.64 | 24.64 | 24.64 | 24.64 |
Altman Z″-Score (non-manufacturers) |
(0.18) | 0.61 | 0.96 | 1.60 | 2.42 | 1.22 | (6.41) | (9.82) | — | — |
P/FCF ratio |
10.29 | 15.80 | 27.94 | 21.24 | 92.84 | 116.01 | 75.95 | 75.95 | 75.95 | 75.95 |
Beneish M-Score |
(2.40) | (2.94) | (2.70) | (2.86) | (2.33) | (3.66) | (2.19) | — | — | — |
P/Operating CF |
29.36 | 40.09 | 145.32 | 61.00 | 268.99 | 746.21 | 304.01 | 304.01 | 304.01 | 304.01 |
P/B ratio |
1.57 | 2.48 | 3.03 | 2.39 | 16.11 | 15.58 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
7.92 | 6.85 | 7.94 | 6.88 | 32.43 | 26.81 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.50 | 2.32 | 3.05 | 2.41 | 17.60 | 19.57 | 25.93 | 25.93 | 25.93 | 25.93 |
EV/EBITDA |
6.83 | 13.32 | 27.25 | 31.12 | 255.30 | 0.00 | 70.22 | 70.22 | 70.22 | 70.22 |
EV/Operating CF |
7.10 | 9.99 | 16.56 | 12.58 | 73.39 | 82.05 | 73.20 | 73.20 | 73.20 | 73.20 |
EV/FCF |
12.70 | 16.18 | 27.75 | 20.16 | 90.91 | 112.82 | 79.93 | 79.93 | 79.93 | 79.93 |
Quick Ratio |
2.02 | 4.80 | 6.66 | 11.46 | 13.06 | 17.47 | 2.22 | 4.09 | 0.00 | 0.00 |
Current Ratio |
2.61 | 5.32 | 7.12 | 12.05 | 13.42 | 18.24 | 2.59 | 4.40 | — | — |
Net Debt/EBITDA |
1.30 | 0.31 | (0.19) | (1.66) | (5.41) | 1.20 | 4.12 | 7.79 | 1.99 | 0.79 |
Debt/Assets |
34.78% | 35.42% | 41.32% | 41.06% | 41.23% | 45.36% | 173.46% | 229.43% | 0.00% | 15.54% |
Debt/Equity |
0.79 | 0.68 | 0.86 | 0.81 | 0.80 | 0.94 | (1.91) | (1.70) | (1.58) | 5.75 |
Asset Turnover |
0.57 | 0.53 | 0.47 | 0.48 | 0.48 | 0.59 | 1.11 | 0.82 | 1.06 | 0.34 |
Operating CF/Net income |
5.52 | 11.22 | (15.59) | (4.47) | (7.08) | (0.45) | 1.95 | 3.18 | 0.00 | 0.00 |
Capex/Depreciation |
(0.85) | (0.98) | (0.50) | (0.96) | (0.91) | (1.64) | (0.34) | (0.31) | — | — |
Interest Coverage |
2.05 | 1.24 | (0.48) | 0.05 | 0.57 | (9.88) | 2.82 | 3.48 | 14.39 | 10.62 |
| 4.54% | 2.21% | (1.12%) | (3.99%) | (3.27%) | 156.09% | (3.80%) | (2.01%) | (4.29%) | 3.77% | |
| 2.18% | 1.10% | (0.56%) | (2.04%) | (1.64%) | (31.62%) | 12.19% | 4.66% | 5.98% | (2.67%) | |
ROIC |
6.49% | 5.36% | (2.26%) | 0.15% | 1.51% | (42.37%) | 29.66% | 18.41% | 0.00% | 0.00% |
Return on Tangible Assets |
7.44% | 2.99% | (1.16%) | (3.80%) | (2.45%) | (27.97%) | 77.62% | 24.77% | 0.00% | 0.00% |
Average Days of Receivables |
107.98 | 67.23 | 69.86 | 55.78 | 57.82 | 45.55 | 45.25 | 48.80 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
15.19% | 15.62% | 18.11% | 18.67% | 16.88% | 11.22% | 7.55% | 17.59% | 7.31% | 5.78% |
Selling, General and Administrative Expense of Revenue |
55.91% | 61.21% | 62.22% | 65.54% | 70.42% | 130.12% | 49.37% | 45.10% | 52.95% | 64.80% |
Intangible Assets out of Total Assets |
0.35 | 0.33 | 0.30 | 0.33 | 0.26 | 0.20 | 0.67 | 0.75 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
9.62% | 12.50% | 13.97% | 15.69% | 21.53% | 72.14% | 0.97% | 0.71% | 0.00% | 0.00% |
Graham Net Nets |
(0.15) | 0.00 | 0.02 | 0.07 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 |
Graham Number |
1.87 | 1.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
3.33% | 1.02% | (0.32%) | (1.66%) | (0.17%) | (2.66%) | 0.72% | 0.72% | 0.72% | 0.72% |
Free Cash Flow Yield |
9.72% | 6.33% | 3.58% | 4.71% | 1.08% | 0.86% | 1.32% | 1.32% | 1.32% | 1.32% |
Revenue per Share |
2.24 | 2.05 | 1.83 | 1.86 | 1.82 | 2.00 | 1.71 | 2.23 | 0.41 | 0.26 |
Operating CF per Share |
0.47 | 0.48 | 0.34 | 0.36 | 0.44 | 0.48 | 0.37 | 0.40 | 0.00 | 0.00 |
Capex per Share |
(0.21) | (0.18) | (0.14) | (0.13) | (0.08) | (0.13) | (0.03) | (0.03) | 0.00 | 0.00 |
Free Cash Flow per Share |
0.26 | 0.29 | 0.20 | 0.22 | 0.35 | 0.35 | 0.34 | 0.37 | 0.00 | 0.00 |
Cash per Share |
0.73 | 1.16 | 1.64 | 1.83 | 2.30 | 3.54 | 0.12 | 0.31 | 0.05 | 0.06 |
Shareholders Equity per Share |
1.73 | 1.88 | 1.86 | 1.97 | 2.03 | 2.59 | (1.55) | (3.80) | (0.22) | 0.02 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.73 | 1.88 | 1.86 | 1.97 | 2.03 | 2.59 | (1.55) | (3.80) | (0.22) | 0.02 |
Free Cash Flow |
93.88 | 113.55 | 82.53 | 91.57 | 144.32 | 95.52 | 77.54 | 41.80 | — | — |
Working Capital |
397.10 | 535.35 | 750.23 | 843.37 | 1,007.71 | 1,026.82 | 53.21 | 56.45 | — | — |
Capital Expenditures |
(74.02) | (70.35) | (55.77) | (55.21) | (34.46) | (35.82) | (5.75) | (3.46) | — | — |
Net Current Asset Value |
(144.69) | (4.15) | 45.95 | 129.88 | 312.88 | 327.61 | (650.79) | (667.14) | (136.00) | (46.00) |
EV/EBIT |
13.63 | 27.90 | 0.00 | 1,062.27 | 978.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.09 | 0.09 | 0.07 | 0.07 | 0.05 | 0.07 | 0.01 | 0.01 | 0.00 | 0.00 |
Price to Operating Income |
11.04 | 27.24 | 0.00 | 1,118.85 | 999.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
7.09 | 5.69 | 6.97 | 2.91 | 1.76 | 0.95 | 9.12 | 11.18 | — | — |
Cash ROIC |
6.87% | 6.82% | 3.95% | 4.10% | 5.93% | 4.06% | 22.38% | 12.61% | 0.00% | 0.00% |
Accounts Receivable Turnover |
4.18 | 5.47 | 5.75 | 6.52 | 7.98 | 9.43 | 9.53 | 6.16 | 0.00 | 0.00 |
Accounts Payable Turnover |
3.43 | 1.91 | 2.48 | 3.70 | 3.36 | 3.26 | 1.86 | 0.80 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
122.97 | 107.02 | 197.79 | 99.27 | 136.74 | 126.95 | 204.45 | 435.46 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
190.84 | 144.77 | 130.37 | 117.61 | 93.40 | 58.43 | 40.74 | 40.50 | — | — |
Average Payables |
16.77 | 25.20 | 26.98 | 17.60 | 13.90 | 9.07 | 7.53 | 7.50 | — | — |
Average Assets |
1,396.06 | 1,488.43 | 1,596.72 | 1,606.13 | 1,538.87 | 928.46 | 350.79 | 305.40 | 148.00 | 291.50 |
Average Common Equity |
670.46 | 743.31 | 788.39 | 823.25 | 771.52 | (188.11) | (1,125.00) | (707.71) | (206.00) | (206.00) |
Columns are period end dates